Cognition Therapeutics to Give Webcast Presentation at Annual Piper Jaffray Healthcare Conference on December 3, 2019
Press Release
, December 3rd, 2019
Cognition Therapeutics Expands Leadership Team with Appointment of James M. O’Brien as Chief Financial Officer
Press Release
, November 4th, 2019
Cognition Therapeutics Sponsoring Satellite Symposium on “Sigma-2 Receptors: Role in Health and Disease” during Society for Neuroscience Annual Meeting
Press Release
, October 15th, 2019
Cognition Therapeutics to Present Findings from the Elayta™ Clinical Development Program at Society for Neuroscience Annual Meeting
Press Release
, October 10th, 2019
Cognition Therapeutics’ Founder/CSO to Provide Update on Elayta™ Clinical Progress at ADDF Alzheimer’s Drug Discovery Conference
Press Release
, September 10th, 2019
COGNITION THERAPEUTICS
WQED
, September 10th, 2019
Cognition Therapeutics’ Founder/CSO to Provide Update on Elayta™ Clinical Progress at ADDF Alzheimer’s Drug Discovery Conference
Intrado
, September 10th, 2019
Cognition Therapeutics to Give Webcast Presentation at 3rd Annual Janney Healthcare Conference on September 9, 2019
Press Release
, September 4th, 2019
Cognition Therapeutics Extends IP Coverage of Alzheimer’s Therapeutic Elayta™ to Additional Major Pharmaceutical Markets with Patent Issuances in Japan and China
Press Release
, July 24th, 2019